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Abstract 
Our previous studies revealed that leukocyte infiltration could trigger breast and prostate 
tumor invasion through physical disruption of tumor capsules.    Our current study, involving 
multiple types of human tumors, further suggests that leukocyte infiltration also triggers 
metastasis through the following pathways : 1) the physical movement into the epithelium 
disrupts inter-cellular junctions and surface adhesion molecules, which cause the disassocia-
tion of tumor cells from  tumor cores, 2) some of these tumor cells subsequently form 
tight junctions with the plasma membranes of leukocytes creating  tumor cell–leukocyte 
chimeras (TLCs), and 3) the leukocytes of TLCs impart migratory capacity to associated 
tumor cell partners.  Our findings suggest a novel pathway for tumor cell dissemination 
from primary sites and journey to new sites.   
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The epithelium, which is the origin of over 85% 
of breast malignancies, is physically separated from 
the stroma by the myoepithelial cell layer and base-
ment membrane [1]. The epithelium is normally de-
void of lymphatic ducts and blood vessels, and thus, 
totally relies on the stroma for its essential needs.  
The epithelial cells are normally held in place by in-
tercellular junctions and surface adhesion molecules 
[2]. Due to these structural relationships, the disrup-
tion of these structures is a pre-requisite for tumor 
invasion into the stroma, which is believed to be a 
multistage process, progressing sequentially from 
normal to hyperplasia, to in situ, and to invasive 
stages [3].  Progression from an in situ to invasive 
stage is believed to be triggered by overproduction of 
proteolytic enzymes primarily by cancer cells [4,5].  
Tumor metastasis is also believed to be a multistage 
process, requiring the tumor cells to dissociate from 
the primary site, enter the circulation, migrate to dis-
tant sites, and proliferate (6).  The mechanism of tu-
mor metastasis, however, remains as a subject of de-
bate.   
Recently, there has been a great deal of interest 
in the role of immune cells in tumor invasion and 
metastasis, and several models, including paracrine 
loop signaling, tumor-educated macrophages, im-
mune cell-based mediation, and cancer cell-leukocyte 
fusion [7-11], have been proposed to explain how 
immune cells could facilitate metastasis. Collectively, 




mor invasion and metastasis through the following 
mechanisms: (1) macrophages enhance tumor cell 
migration through secretion of chemotactic and 
chemokinetic factors, which promote angiogenesis 
and fibrillogenesis, allowing tumor cells track along 
collagen fibers to blood vessels [7,8], (2) 
T-lymphocytes indirectly promote invasion and me-
tastasis by directly regulating the phenotype and ef-
fector function of tumor associated 
CD11b(+)Gr1(-)F4/80(+) macrophages [9,10], and (3) 
macrophages ingest tumor cells, resulting in the fu-
sion of genetic materials of two cell types that creates 
a hybrid phenotype [11].  Each of these models is 
supported by laboratory findings or clinical data, 
suggesting that metastasis is likely to occur through 
multiple mechanisms.   However, it is not currently 
possible to discern the mechanistic origin of a given 
metastatic lesion.  In addition, two critical issues re-
main: (1) how metastasis-initiating cells are dissemi-
nated from their primary sites, and (2) how dissemi-
nated tumor cells escape from the im-
mune-surveillance during their journey to new sites.  
More importantly, the specific molecule and unique 
morphological feature of pending or early metastatic 
lesions remain elusive, making it difficult for early 
detection and intervention of tumor metastasis.  
Since the loss of the myoepithelial cell layer is the 
primary pathological criterion for the diagnosis of 
invasive breast lesions (1), our recent studies have 
attempted to identify early alterations of this layer.  
Of over 8,000 ducts and acini examined from over 400 
cases, our study revealed that about 10% of patients 
harbored a high frequency of focal disruptions in the 
myoepithelial cell layers of ducts or acini with 
pre-invasive tumors.  Ducts and acini with a focally 
disrupted myoepithelial cell layer had a significantly 
higher frequency of leukocyte infiltration than their 
counterparts with non-disrupted layers, 97.4% versus 
22.2%, and a vast majority of infiltrated leukocytes 
were located at or near the disruptions [12-15]. 
Epithelial cells overlaying disruptions had a signifi-
cantly higher frequency of ER negativity, elevated 
proliferation, aberrant DNA structural alterations, 
and expression of invasion and metastasis-related 
genes than their counterparts within the same duct 
but distant from disruptions [12-15].  Our findings 
have led to a novel hypothesis that breast tumor in-
vasion is triggered by focal myoepithelial cell degen-
eration induced leukocyte (mainly CD8 (+) and CD 
4(+) lymphocytes) infiltration that results in focal 
disruptions in the myoepithelial cell layer, which se-
lectively favor monoclonal proliferation and stromal 
invasion of tumor progenitors overlying these dis-
ruptions [16].   
Our more recent studies have further shown that 
aberrant leukocyte infiltration may also represent a 
trigger factor for tumor metastasis through the path-
ways depicted in Fig 1.    
This hypothesis fundamentally differs from ex-
isting theories of tumor metastasis [7-11].  Based on 
this hypothesis, leukocytes (mainly T-lymphocytes) 
could directly trigger tumor invasion and metastasis 
through three correlated pathways: (1) physical dis-
ruptions of the inter-cellular junctions and surface 
adhesion molecules, causing tumor cell dissociation 
from primary sites, (2) formation of tight junctions 
with the plasma membrane of tumor cells, allowing 
leukocytes to physically drag their partners to distant 
sites during their migration, and (3) formation of tight 
junctions with the plasma membranes of mitotic cells, 
interfering with the cell division process.  Our recent 
studies with confocal microscope have confirmed the 
tight plasma membrane junctions between leukocytes 
and tumor cells [17].  The mechanism for the forma-
tion of tight membrane junctions between leukocytes 
and tumor cells is unknown, but may involve the 
formation of microvesicles by the tumor cells. Mi-
crovesicles released from the membranes of tumor 
cells contain proteins that may act as self-epitopes 
[18,19], which stimulate production of corresponding 
auto-antibodies, or activate a subset of leukocytes.  
Prior to their release, these microvesicles are small 
particles embedded within the tumor cell plasma 
membrane, and could potentially function as recep-
tors for the leukocytes, leading to the formation of 
TLCs [18, 19].  It is also possible that these dissoci-
ated tumor cells may belong to a population of tumor 
stem cells, which has unique expression of plasma 
membrane-related proteins that function as receptors 
for the leukoc ytes.         
This hypothesis presents a unique explanation 
for the initial dissemination of tumor cells from their 
primary sites and their subsequent journey to new 
sites. If confirmed, it could have several significant 
implications.  Scientifically, it could lead to a new 
direction to acquire more effective approaches for 
detection, intervention, and prevention of invasion 
and metastasis. Clinically, it may have a number of 
beneficial applications, including: (1) double immu-
nostaining to assess the extent of focal myoepithelial 
cell layer disruptions and leukocyte infiltration of in 
situ  tumors may facilitate differentiation between 
those at high or low risk to progress, (2) a quantitative 
assessment of myoepithelial cell degeneration-related 
molecules, or the number of leukocyte subtypes pref-
erentially associated with degeneration-related 
changes in blood samples may be used as a screen tool 




velop invasive or metastatic lesions, and (3) the de-
velopment of therapeutic agents to target the specific 
leukocyte subtypes that are physically associated with 
epithelial cells may provide a more effective means to 
treat and prevent tumor invasion and metastasis.  In 
addition, this hypothesis may be applicable to all 
epithelium-derived tumors, as leukocytes are widely 
distributed in abundance in almost all human tissues.  
 
 
Figure 1. Hypothesized mechanism and steps of leukocytes triggering tumor invasion and metastasis. Human breast and 
lung tissue sections were immunostained with the following biomarkers. A-B. smooth muscle actin (SMA; red). C-D: SMA 
(red) + leukocyte common antigen (LCA; brown). E-J: LCA (red)+cytokeratin (CK) AE 1/3 (brown). K: LCA (brown). L: 
LCA (red)+ Ki-67 (brown). 
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